Injecting poly-ICLC directly into prostate tumors before surgery may reawaken immune activity and help transform resistant ...

A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes.

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Johann S. De Bono discussing emerging new therapeutic strategies for ...

Dilbert” creator Scott Adams announced earlier this year he had been diagnosed with a metastasized prostate cancer. In a post ...

Berries are rich in antioxidants and flavonoids such as anthocyanins, which are anti-inflammatory and can reduce oxidative stress. "These two factors are major drivers of cancer, and berries pack a ...